1The Second Clinical Medical School, Lanzhou University, Lanzhou, China. 2Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China. 3Gansu Tumor Immunology Basic Disciplines ...
Nathan Mantel; The Detection of Disease Clustering and a Generalized Regression Approach. Cancer Res 1 February 1967; 27 (2_Part_1): 209–220. While the distance measures between points represent ...
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. 3Department of Urology, James Buchanan ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Cancer Discov (2025) 15 (12): 2422–2430.
Cancer Discov (2024) 14 (4): 674–682.
The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
Cancer Res (2023) 83 (7_Supplement): 526. RMC-9805 treatment caused selective and persistent modification of KRAS G12D leading to deep and durable suppression of RAS pathway activity, inhibition of ...
Cancer Res (2023) 83 (8_Supplement): LB215.
1Department of Medical Oncology, Gustave Roussy, Villejuif, France.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results